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SUMMARY
The intestinal epithelium has a remarkable capacity to regenerate after injury and DNA damage.
Here, we show that the integrin effector protein Focal Adhesion Kinase (FAK) is dispensable for
normal intestinal homeostasis and DNA damage signaling, but is essential for intestinal
regeneration following DNA damage. Given Wnt/c-Myc signaling is activated following intestinal
regeneration, we investigated the functional importance of FAK following deletion of the Apc
tumor suppressor protein within the intestinal epithelium. Following Apc loss, FAK expression
increased in a c-Myc-dependent manner. Codeletion of Apc and Fak strongly reduced proliferation
normally induced following Apc loss, and this was associated with reduced levels of phospho-Akt
and suppression of intestinal tumorigenesis in Apc heterozygous mice. Thus, FAK is required
downstream of Wnt Signaling, for Akt/mTOR activation, intestinal regeneration, and
tumorigenesis. Importantly, this work suggests that FAK inhibitors may suppress tumorigenesis in
patients at high risk of developing colorectal cancer.
INTRODUCTION
A number of studies have shown that the integrin effector kinase pathway that involves Src
and FAK is upregulated in colorectal cancer. Although levels of Src and FAK are
deregulated at all stages of colorectal carcinogenesis (Cance et al., 2000; Theocharis et al.,
2003), most studies have focused upon the importance of these proteins in colorectal cancer
(CRC) invasion and metastasis (McLean et al., 2005; Serrels et al., 2006). Therefore, very
little is known about the mechanism of Src/FAK deregulation at the early stages of cancer,
including the functional importance of their elevated expression or indeed their role in
normal tissue homeostasis.
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The intestinal epithelium provides one of the best model systems to study epithelial stem
cells, differentiation, regeneration, and cancer. Unlike many other epithelia, the position of
the intestinal epithelial stem cell is known, allowing characterization of the number and
properties of these stem cells within the intestinal crypt-villus architecture (Potten, 1998;
Barker et al., 2008). Indeed, elegant experiments have defined LGR5/GPR49 (a Wnt target
gene) and Bmi1 as intestinal stem cell markers in murine small intestine and colon (Barker
et al., 2007; Sangiorgi and Capecchi, 2008). Moreover, these cells may be the cell of origin
for intestinal cancers (Barker et al., 2009).
The intestinal epithelium has a remarkable capacity to regenerate following DNA damage
(Bach et al., 2000), injury (e.g., acute colitis), surgical resection (Bernal et al., 2005), and
after Cre-mediated deletion of genes that are essential for intestinal homeostasis (Ireland et
al., 2004). This latter process leads to rapid repopulation of the intestine from
nonrecombined cells (i.e., those cells which have not undergone Cre recombinase-mediated
excision of the LoxP flanked gene of interest and so have not deleted the gene that is
essential for intestinal homeostasis). In all cases, the process of intestinal regeneration is
characterized by a marked burst of proliferation within the crypt, with an associated
transient crypt enlargement (Ijiri and Potten, 1986). Despite this wealth of biological
information, very little is known about the molecular pathways important for stem cell
maintenance and repopulation within the intestine. In previous studies we found high levels
of β-catenin and c-Myc in regenerating intestinal crypts following loss of the genes
important for intestinal homeostasis (Ireland et al., 2004; Muncan et al., 2006). Wnt pathway
activation has been suggested as the mechanism that allows the intestine to regenerate
following Mdm2 deletion (Valentin-Vega et al., 2008). However, the functional significance
of the enhanced Wnt signaling is unclear.
In the present work, we show that FAK is deregulated immediately following loss of the
Apc protein and levels are increased during intestinal regeneration. Given that previous data
have shown that FAK is important for preventing apoptosis (including progenitor cell
apoptosis in the skin) (Frisch et al., 1996; Hungerford et al., 1996; McLean et al., 2004), and
for wound healing in vitro (Essayem et al., 2006) (where there are often high levels of Wnt
signaling), we addressed whether FAK was required for intestinal regeneration and Wnt-
driven tumorigenesis in vivo. We established that FAK is essential for both of these
processes, and contributes to Wnt-mediated induction of the Akt/mTOR pathway.
RESULTS
FAK Is Upregulated during Intestinal Regeneration and Transformation in a c-Myc-
Dependent Manner
Given that FAK expression is upregulated in CRC and deregulated Wnt signaling is a key
event in CRC, we addressed whether FAK expression was elevated following activation of
Wnt signaling within the intestinal epithelium, either during intestinal regeneration or
following acute activation of Wnt signaling due to Apc loss. We found that while FAK is
weakly expressed in the normal murine intestinal epithelium (Figure 1A), it is clearly
upregulated during intestinal regeneration (Figure 1B) and following Apc gene deletion
(Figures 1D and 1E). Given our previous studies showing that c-Myc is an essential
downstream target fol lowing Apc loss (Sansom et al., 2007), we next showed that c-Myc
was essential for elevated expression of FAK either during intestinal regeneration after DNA
damage or following Apc loss (Figures 1C, 1F, and 1G). To examine if this was due to a
change in the transcriptional levels of FAK, we performed qRTPCR in wild-type, Apc-
deficient, and Apc/c-Myc double-knockout intestines. FAK expression was increased by 2-
fold in the Apc-deficient intestines and reduced back to wild-type levels in the double Apc/
Myc mutant intestines (fold change relative to wild-type: Apc 2, Apc/Myc:0.82, Apc versus
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Apc/Myc p value: 0.001). High FAK expression was maintained in intestinal adenomas
from the Apcfl/+ mouse suggesting that high FAK expression may play a role in Wnt-
dependent tumorigenesis following Apc loss (Figure 1H).
Although we, and others, have previously shown that Wnt and c-Myc signaling is activated
during intestinal regeneration, we had not proved that this was “driving” regeneration.
Therefore, we tested whether c-Myc-deficient enterocytes could regenerate following
gamma irradiation (Potten and Grant, 1998). Conditional deletion of the gene encoding c-
Myc in the murine small intestine was achieved by crossing mice carrying LoxP-flanked c-
Myc alleles with mice carrying the Cre recombinase transgene under the control of the
Cyp1A1 aryl hydrocarbon-responsive promoter (AhCre) (Ireland et al., 2004; Muncan et al.,
2006). Cre-mediated excision was induced by intraperitoneal injection of β-naphthoflavone.
This induces Cre expression within the small intestinal crypt and also in hepatocytes (Ireland
et al., 2004; Sansom et al., 2004, 2005). When using an induction regimen that yields
maximal recombination (three injections spaced 4 hr apart) (Sansom et al., 2007), nearly
100% recombination is achieved in Cre+ mice as scored through β-galactosidase staining
using the Rosa26R surrogate marker of recombination (Soriano, 1999).
Successful regeneration results in large hyperproliferative crypts indicated by the black
arrows in Figure 2A (72 hr following the DNA damage insult). If this does not occur, crypts
are either completely ablated or are in the process of dying (shown by the red arrows in
Figure 2B). These “dying” crypts are composed of less than six consecutive epithelial cells
and are often cystic. The number of surviving crypts can be counted by using hematoxylin
and eosin (H&E)-stained sections from control and Myc-deficient intestine, to assess
whether c-Myc is required for crypt survival (Potten, 1998). Figure 2 shows that Cre+Myc+/+
(control) intestinal crypts regenerate efficiently after treatment with 14 Gy gamma
irradiation, while Cre+Mycfl/fl crypts do not regenerate, with no c-Myc-deficient crypts being
present 72 hr after irradiation (compare Figures 2A and 2B; see Figure S1A available
online). The only surviving crypts had “escaped” the recombination event and showed high
expression of c-Myc (and FAK) as shown by immunohistochemistry (IHC) (Figures 2D and
2E, see black arrows highlighting enlarged crypts with c-Myc staining, 2H enlarged crypt
with FAK staining). From here on, we will describe these crypts as “escapers,” which serve
as excellent internal controls for immunohistochemical comparisons. Importantly, we can
show using serial sections that the escaper c-Myc-positive crypts also have high levels of
FAK when compared with the surrounding recombined Myc-deficient dying crypts (Figures
S1B–S1E).
One of the difficulties with this analysis is that although c-Myc-deficient intestinal crypts
can survive over the short term following c-Myc deletion, over the long term they are lost
(Muncan et al., 2006). To deal with this problem, we intercrossed the AhCre Mycfl/fl mice
with mice carrying a Lox-STOP-Lox c-myc allele targeted to the Rosa26 locus (X.W., M.
Cunningham, S. Tokarz, B. Laraway, X. Zhang, H. Arnold, M. Troxell, and R.C.S.,
unpublished data). This allele delivers physiological levels of c-Myc (equivalent to wild-
type Myc) following Cre-mediated recombination, but as it is under the control of the
Rosa26 promoter (instead of its own promoter) it is not inducible by Wnt signaling.
Following Cre induction, AhCre Mycfl/flRosac-Myc/+ intestinal enterocytes proliferated as in
wild-type mice and cells were not lost over the long term (Figure S1F). This allowed us to
specifically address the role of c-Myc that is induced by Wnt following irradiation. We
found that intestinal regeneration was markedly reduced in the AhCre Mycfl/flRosac-Myc/+
mice with few surviving intestinal crypts, despite the presence of c-Myc (Figures 2F and 2G;
Figures S1G–S1I). Importantly, FAK levels were much reduced in these AhCre
Mycfl/flRosac-Myc/+ poorly regenerating crypts (Figures 2H and 2I), suggesting FAK may be
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an essential downstream target of c-Myc signaling during intestinal regeneration and
oncogenic transformation in the mouse intestine in vivo.
FAK Is Redundant for Normal Intestinal Homeostasis but Is Required for Intestinal
Regeneration
We next addressed whether FAK plays a role in intestinal homeostasis. Mice carrying LoxP-
flanked Fak alleles (McLean et al., 2004) were intercrossed to mice carrying the AhCre
transgene. To investigate the phenotype of loss of FAK from the intestinal epithelium in the
adult mouse, experimental AhCre+Fakfl/fl animals and control AhCre+Fak+/+ animals were
induced and euthanized and intestines were analyzed at 4, 18, 150, and 350 days
postinduction. At day 4 after cre induction, intestines were stained for activity of the LacZ
recombination reporter transgene (Rosa26R), which showed that there was near 100%
recombination in AhCre+Fakfl/fl animals, and this level of recombination remained stable for
over 350 days (Figure S2A). Using IHC, no appreciable staining was observed 4 days after
gene deletion, and this protein loss was maintained indefinitely (Figure S2B).
Immunoblotting for FAK protein also showed a loss of protein at day 4 (Figure S2C).
Despite FAK deletion, intestinal homeostasis was not altered, with normal levels of
proliferation, differentiation, apoptosis, and migration (Figure S2).
Next, we investigated whether FAK was important for intestinal regeneration. Therefore, 4
days after cre induction, AhCre+Fak+/+ and AhCre+Fakfl/fl mice were irradiated with 14 Gy
gamma irradiation. At 72 hr, mice were euthanized and the small intestines removed. We
found an almost complete absence of hyperproliferative crypts in FAK-deficient animals
(Figure 3A, right-hand panel and Figure 3B). Indeed, the few live crypts that remained were
all escapers (described above), retaining high expression of FAK (judged by IHC and shown
by black arrows in Figure 3C). Moreover, FAK deficiency also prevented regeneration
following cisplatin treatment (Figure S3E).
Given the considerable amount of literature that links FAK to cell survival and suppression
of apoptosis (Crouch et al., 1996; Frisch et al., 1996; Hungerford et al., 1996; McLean et al.,
2004; Lim et al., 2008), it was possible that rather than affecting the regrowth of intestinal
crypts, FAK-deficient crypts were dying due to increased apoptosis as a result of gamma
irradiation. Therefore, we examined whether Fak deletion affected the ability of intestinal
enterocytes to enter an apoptotic program following DNA damage. Experimental and
control animals at day 4 after cre induction were exposed to 14 Gy gamma irradiation and
tissues were harvested 6 and 24 hr after exposure. Histological sections from these animals
were examined and levels of apoptosis scored. In both groups, irradiation caused a large
increase in the number of apoptotic figures and a reduction in mitotic figures. However,
FAK deficiency did not significantly alter either the levels of apoptosis or mitosis (Mann-
Whitney p ≥ 0.5, n = 6) (Figure S3A). Consistent with this, p53 and its target gene p21 were
both induced irrespective of FAK status (Figures S3B–S3D). To investigate whether this
was an agent-or dose-specific effect, we also investigated the levels of apoptosis and p53
and p21 induction following 5 Gy irradiation, or treatment with 10 mg/kg cisplatin. There
were no significant differences between control and experimental animals (Figures S3A–
S3C). Taken together, these findings show that FAK is not required for (nor does it
exacerbate) p53-dependent apoptosis following high levels of DNA damage in the intestinal
epithelium.
Although levels of apoptosis were equivalent at the early stages following DNA damage,
during the regrowth phase of the intestinal epithelium at 48 hr, AhCre+Fakfl/fl mice had
higher levels of apoptosis and reduced levels of proliferation compared with wild-type
regenerating intestines (Figures 3D and 3E). These data suggest that while FAK is not
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required for homeostatic proliferation, it is required for the burst of proliferation during
intestinal regeneration which is associated with high levels of Wnt signaling.
Our previous studies have shown that the AhCre expression is restricted to the epithelium of
the murine small intestine, and so FAK should not be deleted in nonintestinal epithelial
cells. Endothelial cells are also important for the regeneration process, but we found that
conditional deletion of FAK within the intestinal epithelium did not affect apoptosis of
endothelial cells following 14 Gy irradiation (median endothelial apoptosis per villus 5.12
[WT] v 5.22 [FAK] 6 hr following irradiation, Mann-Whitney p = 0.66, n = 3). However,
given the AhCre transgene also yields recombination in other tissues (predominantly the
liver), we also generated VillinCreERFakfl/fl mice to ensure that our pheno-type was indeed
due to deletion of FAK specifically within the intestine. Consistent with our studies in the
AhCre mice, we again found that FAK was redundant for normal intestinal homeostasis, and
did not affect short-term irradiation induced apoptosis (data not shown), but was absolutely
required for intestinal regeneration following DNA damage (Figures 3F and 3G). Indeed,
using Villin-CreER, even fewer escaper, nonrecombined crypts survived. Taken together, our
data show unequivocally that FAK is required for the hyperproliferative response and
regrowth of the intestinal crypts (hence regeneration) after gamma-irradiation.
FAK Is Required to Induce Signaling to Akt/mTOR during Intestinal Regeneration
We next investigated what signaling downstream of FAK was linked to its requirement for
intestinal regeneration. One of the key downstream effectors of FAK signaling demonstrated
in vitro is the PI3 kinase-Akt pathway (Gabarra-Niecko et al., 2003; McLean et al., 2005;
Thamilselvan et al., 2007). Therefore, we addressed whether Akt/mTOR signaling was
activated during regeneration, and if so, whether this was FAK dependent. To examine
signaling to Akt, we investigated the expression of phosphorylated active p-AktSer473, and
its targets p-GSK3βSer9 and p-mTORSer2448, as downstream readouts. Figures 4A–4D show
the increased expression of p-Akt, p-GSK3β and p-mTOR in regenerating crypts, consistent
with robust activation of the Akt signaling pathway in regenerating epithelium. To test
whether this was required downstream of FAK signaling, we examined p-Akt in control and
FAK-deficient intestines. p-Akt was not elevated in FAK-deficient crypts during the
regenerative process when compared with controls, while in the few FAK-proficient escaper
crypts, we found high levels of p-Akt, similar to levels in wild-type regenerating crypts
(Figure 4A, black arrows indicate regenerating escaper crypts, red arrows indicate FAK-
deficient crypts). p-Akt was also not visibly elevated in c-Myc-deficient crypts (Figure 4B,
black arrow indicates regenerating escaper crypt, red arrows indicate c-Myc-deficient
crypts), arguing that, Wnt/Myc signaling is upstream of signaling to Akt and is mediated by
FAK.
In addition to signaling to Akt itself, two downstream targets, namely, GSK3β and mTOR,
were also phosphorylated in wild-type regenerating crypts after irradiation (Figures 4C and
4D). Importantly, only regenerating FAK-proficient crypts showed upregulation of p-
mTOR, whereas p-mTOR could not be visualized in FAK-deficient crypts (Figure 4D). We
confirmed this upregulation of p-Akt and p-mTOR in regenerating FAK-proficient escaper
crypts using serial sections (Figure 4E). Consistent with FAK being the key downstream
target of c-Myc, AhCre Mycfl/flRosac-Myc/+, intestines which failed to regenerate (or
upregulate FAK) also did not display increased levels of p-Akt or p-mTOR (Figures S1J and
S1K).
To test whether the lack of elevated Akt/mTOR signaling was functionally important, we
treated wild-type mice with either PI103 (a PI3 kinase inhibitor (Raynaud et al., 2007)) or
rapamycin (an inhibitor of the Akt-mediated phosphorylation of mTOR) and found both
agents significantly reduced the number of surviving crypts following ionizing radiation
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(Figure 4F). These data imply that a pathway linking Wnt signaling via c-Myc to Akt and
mTOR is mediated by FAK and is critically required for intestinal regeneration. This
provides a functional link between the Wnt and integrin signaling pathways in which FAK
serves to connect Wnt- and integrin-dependent activation of Akt/mTOR signaling in vivo.
Activating Akt Signaling Independently of FAK Permits Regeneration
The finding that PI3 kinase or mTOR inhibition inhibits regeneration correlated with the
failure of signaling to Akt/mTOR in the FAK-deficient intestinal enterocytes. To test
causality, we activated Akt signaling, independently of FAK, to determine if this rescued
regeneration in FAK-deficient intestines. One method known to stimulate Akt in the
intestinal epithelium is to inject mice intravenously with IGF1 (insulin-like growth factor 1),
and this has been shown to increase intestinal regeneration by stimulating Akt if given at the
time of irradiation (Booth and Potten, 2001). Moreover, a recent study investigating the
transcriptome of FAK-deficient mammary epithelial tumors showed a marked upregulation
of IGFR (IGFI-receptor) (and GRB2) suggesting that FAK-deficient cells should remain
responsive to IGF (Provenzano et al., 2008). Therefore, given our hypothesis that lack of
Akt activation (due to FAK deletion) at the later stages of the regeneration process (48–72
hr) was contributing to failed regeneration, we injected mice with IGF1 24, 36, and 48 hr
following irradiation (after the peak of DNA damage-induced apoptosis). This rescued the
failed regeneration caused by FAK deficiency, with evidence of large hyperproliferative
FAK-deficient crypts (Figures 5A–5C, red arrows indicate FAK-deficient regenerating
crypts, black arrows indicate regenerating escaper FAK-proficient crypts). Moreover p-Akt
and p-mTOR were now visible in all regenerating crypts (Figures 5D and 5E). These data
demonstrate that FAK is required to link the Wnt and Akt/mTOR pathways during intestinal
regeneration.
FAK Is Required for Intestinal Transformation following Apc Loss
We next wished to test if FAK was also required for oncogenic transformation downstream
of Apc loss. Hence, we intercrossed AhCre+Apcfl/fl mice to AhCre+Fakfl/fl mice to generate
double-mutant AhCre+Apcfl/flFakfl/fl mice. Mice were induced with β-naphthoflavone as
described previously, and the phenotypes of the intestines were analyzed 4 days after gene
deletion. Apc-deficient intestinal enterocytes displayed a crypt progenitor cell-like
phenotype, with marked hyperproliferation and nuclear β-catenin in every cell as described
previously (Sansom et al., 2004). AhCre+Apcfl/flFAKfl/fl intestinal crypts were smaller,
showed an absence of FAK expression, and showed a significant reduction in proliferation
(as measured by BrdU incorporation) 4 days after cre induction, when compared with
AhCre+Apcfl/fl mice (Figures 6A–6C; Figure S4A). Moreover, they displayed increased
levels of apoptosis (Figure 6C).
We next wished to test if the same Myc/FAK/p-AKT/mTOR pathway that was promoting
regeneration was driving transformation following Apc loss. The double-knockout Apc/Fak
(AhCre+Apcfl/flFAKfl/fl) intestines were used to test this hypothesis directly. Since we
predict that FAK would be downstream of β-catenin and c-Myc, and upstream of Akt/
mTOR, the Apc/FAK double-knockout intestines should display high levels of nuclear β-
catenin and c-Myc (equivalent to Apc single knockouts; Figures 6D and 6E) but no increase
in the levels of p-AKT/mTOR. IHC staining showed a marked increased in nuclear β-
catenin and c-Myc staining in Apc/FAK double-knockout intestines compared with wild-
types, which was similar to single Apc knockout intestines (Figures 6D and 6E). In contrast,
much lower levels of p-Akt/p-mTOR were observed by both IHC and immunoblotting in the
double knockout when compared with single Apc knockout intestines (Figures 6F and 6G;
Figure S4B). This genetic experiment directly demonstrates that FAK is required for
efficient activation of p-Akt/mTOR following Apc loss and induced c-Myc expression.
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To test the long-term significance of Fak deletion to Apc-deficient cells, we next
investigated whether FAK deficiency slowed tumorigenesis in mice heterozygous for Apc
loss. Cohorts of 20 AhCre+Apcfl/+Fak+/+ mice and 20 AhCre+Apcfl/+Fakfl/fl mice were given
three injections of 80 mg/kg β-naphthoflavone at weaning to induce loss of one Apc allele,
and mice were aged until they developed intestinal adenomas. As we have shown
previously, adenomas arise following loss of the wild-type Apc allele and mice are culled
when they develop signs of ill health due to intestinal tumorigenesis: anemia (as observed by
white feet) in concert with weight loss and hunching (Sansom et al., 2006; Muller et al.,
2009). All 20 AhCre+Apcfl/+Fak+/+ mice developed symptoms of intestinal tumors, and on
necropsy had numerous intestinal adenomas at 400 days (or earlier) following induction
(consistent with our previous data; Sansom et al., 2006; see Figure 6H). However, none of
the 20 AhCre+Apcfl/+ Fakfl/fl mice developed signs of intestinal disease, but began to die of
nonrelated symptoms due to longevity (lymphoma and hepatocellular carcinoma; Figure
S4E). β-galactosidase staining of AhCre+Rosa26R+Apcfl/+Fakfl/fl whole mounts 500 days
after induction showed retention of LacZ-positive recombined cells, showing that the
suppression of tumorigenesis was not simply due to the loss of recombined enterocytes
(Figure S4C). Consistent with the retention of the recombined cells, IHC for FAK showed
that the majority of intestinal enterocytes still lacked FAK (Figure S4D). Of the 20
AhCre+Apcfl/+Fakfl/fl mice, 14 showed no signs of ill health and were culled at 500 days
after induction (over 70 days after the last AhCre+Apcfl/+Fak+/+ mouse had been sacrificed;
Figure S4E for survival curve) and only 3 of 20 AhCre+Apcfl/+Fakfl/fl mice developed
intestinal adenomas (with 2 of these only developing a single adenoma; Figure S4F).
Therefore, deletion of Fak almost completely suppressed tumor formation following Apc
loss, highlighting that FAK is required by cells with deregulated Wnt signaling within the
intestinal epithelium for both oncogenic transformation and tissue regeneration after DNA
damage.
DISCUSSION
In this study, we have provided in vivo evidence that crosstalk between the Wnt and integrin
(via FAK) signaling pathways is required for both intestinal homeostasis and cancer. This
pathway is critical for cell survival, as without FAK to link the Wnt and Akt/mTOR
pathways, there is a switch from the proproliferative activity of the Wnt signaling pathway
to an apoptotic response. This finding fits with recent data showing that mTOR is critical
downstream of Wnt signaling for stem cell depletion in the skin and that rapamycin can slow
tumorigenesis in the ApcMin/+ mouse (Fujishita et al., 2008; Castilho et al., 2009).
Our previous studies have identified that the c-Myc oncoprotein is essential for all the
phenotypes of Apc deficiency within the intestinal epithelium (Sansom et al., 2007; Wilkins
and Sansom, 2008). Here, we now extend this c-Myc dependency to intestinal regeneration.
Importantly, this is not simply a reflection of functionally compromised c-Myc-deficient
intestinal enterocytes as mice carrying physiological levels of c-Myc, which is not Wnt
inducible, are unable to undergo efficient intestinal regeneration. This reinforces how critical
the levels of c-Myc are for biological outcome and is consistent with recent studies showing
that the threshold of c-Myc activity governs apoptotic versus proliferative outcomes in vivo
(Murphy et al., 2008). Indeed, following Apc loss, there is only a 4-fold induction of c-Myc
mRNA and reducing this by even 2-fold can suppress proliferation and tumorigenesis
(Athineos and Sansom, 2010; Yekkala and Baudino, 2007). It is thus essential to delineate
the critical downstream pathways of c-Myc that are responsible for the effects of these
relatively small changes in c-Myc expression. Our current identification of FAK and p-Akt/
mTOR as key downstream effectors of this pathway is therefore important. Indeed, FAK is
often viewed as a critical determinant of apoptosis in a number of different systems
(Parsons, 2003; Mitra and Schlaepfer, 2006), and it is thus tempting to speculate that FAK
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expression may be an important requirement of cells with high levels of c-Myc to permit
survival. Moreover, FAK deletion has reduced tumorigenesis in a number of different
cellular contexts (such as mammary and skin carcinogenesis) where c-Myc deletion (or
mTOR inhibition) have also been shown to suppress tumorigenesis, suggesting that the
pathway identified in the present study in mouse intestine may be relevant for numerous
different cancer settings (Lahlou et al., 2007; Amornphimoltham et al., 2008; Provenzano et
al., 2008). Therefore, we may have uncovered a more general role for FAK, downstream of
activated Wnt signaling, in a number of biological contexts, such as development, tissue
regeneration after damage, and tumorigenesis.
Although FAK is upregulated in numerous cancers, very little is known about the
mechanism that causes elevated expression (Gabarra-Niecko et al., 2003; McLean et al.,
2005). Of particular relevance to our study is that FAK can be coamplified with c-MYC in
cancer (Agochiya et al., 1999) and that N-Myc can transcriptionally activate FAK in
neuroblastoma (Beierle et al., 2007). Our finding that the precise c-Myc levels control FAK
expression is therefore an important step in unraveling the precise molecular regulators of
FAK levels in cancer. We are currently undertaking further work to assess if this is due to
direct transcriptional control of FAK by c-Myc or whether this is through an indirect
mechanism.
With regard to the lack of impact of Fak deletion on normal intestinal epithelium, we note
that this phenotype differs somewhat from the phenotype of ITGB1 (integrin β1) deletion in
the intestine (Jones et al., 2006). Mice lacking β1-integrin solely within the intestinal
epithelium show hyperproliferation and post-natal lethality (Jones et al., 2006). However,
the latter study was performed using a constitutive Cre recombinase (Villin Cre) which is
expressed in the embryonic mouse intestine. It is thus possible that there is developmental
compensation between integrin family members that may explain these differences.
Compensation does occur in some circumstances, as some components of integrin signaling
are known to cause upregulation of others to drive proliferation (Reynolds et al., 2009). The
existence of such compensatory mechanisms is further exemplified by the deletion of Stat3,
using Villin Cre, causing activation of Stat1 (Musteanu et al., 2010).
Our finding that Wnt signaling is important for intestinal regeneration fits into the context of
a generic role for Wnt signaling in epithelial tissue regeneration, as studies have identified
activated Wnt signaling in both murine liver and zebrafish tail regeneration (Tan et al.,
2006; Stoick-Cooper et al., 2007). However, given the development of Wnt inhibitors for
cancer therapy (DeAlmeida et al., 2007), it raises the possibility that if these are used in
combination with chemotherapeutic drugs, or radio-therapy, they may exacerbate
gastrointestinal toxicity. Thus, it will be vital to study the impact of Wnt inhibitors on
intestinal regeneration and stem cells following treatment with these genotoxic agents in
preclinical models.
A recent study has suggested that one of the mechanisms by which FAK promotes cell
survival is by control of p53 degradation via the FERM domain of FAK functioning in the
nucleus (Lim et al., 2008). In particular, there is upregulation of p53 at E8.5 in the
mesoderm of Fak−/− embryos. Although genetic knockout of p53 did not rescue the
phenotype of FAK deficiency, the strong proliferation block that occurs in embryonic fibro-
blasts grown in culture was abolished in the double knockouts (Lim et al., 2008). Here, we
failed to find any impact of Fak deletion on p53 levels, either in normal homeostasis or after
DNA damage. This is not too surprising as the level of damage we have used in our study
initiates a robust p53 response with high levels of apoptosis and arrest, and therefore we
would be unlikely to see further enhancement of p53 accumulation. We therefore conclude
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that FAK-mediated stabilization and accumulation of p53 does not occur in vivo in the
intestine, and so may be cell type specific.
In summary, we have shown that FAK is essential downstream of activated Wnt signaling
within the intestinal epithelium. Given the central role of Apc loss in colorectal cancer, this
raises the potential that FAK may be a particularly attractive target for chemopreventive
studies, especially given the redundancy of FAK for normal intestinal homeostasis and the
number of novel FAK inhibitors which are in preclinical development (McLean et al.,
2005).
EXPERIMENTAL PROCEDURES
Mouse Colonies
All experiments were performed under the UK Home Office guidelines. Outbred male mice
from 6 to 12 weeks of age were used, which were segregated for the C57BL6 and S129
genomes. The alleles used were as follows: Apc580S (Shibata et al., 1997), Mycfl/fl (Baena et
al., 2005), AhCre (Ireland et al., 2004), Rosa26R+ (Soriano, 1999), Fakfl/fl (McLean et al.,
2004), and VillinCreER (Andreu et al., 2005). Mice were exposed to gamma-irradiation
137Cs sources. This delivered gamma-irradiation at 0.423 Gy/min.
Rapamycin was made up as a 50 mg/ml stock solution in ethanol and diluted in PBS + 5%
Tween 80, 5% PEG 400. PI103 was made up as a 25 mg/ml stock solution in DMSO and
diluted in PBS + 20% 4-hydroxypropyl β-cyclodextrin.
Tissue Isolation
To induce recombination, mice were given three injections (i.p.), spaced 4 hr apart, of β-
naphthoflavone (80 mg/kg). At the appropriate time point, mice were sacrificed and the
small intestines were removed and flushed with water (at least three mice were used for each
experiment).
β-Galactosidase Analysis
To determine the pattern of recombination at the Rosa26R reporter locus, intestinal whole
mounts were prepared, fixed, and exposed to X-gal substrate using a method previously
reported (Soriano, 1999).
Assaying Crypt Size, Apoptosis, and Mitosis
Apoptosis, crypt size, and mitotic index were scored from H&E-stained sections as
previously described (Sansom et al., 2004). For each analysis, 25 full crypts were scored
from at least three mice of each genotype. In this paper, data are presented as boxplots. All
boxplots express the first (Q1) and third (Q3) quartiles within a given data set by the upper
and lower horizontal lines in a rectangular box, inside which is a horizontal line showing the
median. The whiskers extend upward and downward to the highest or lowest observation
within the upper (Q3 + 1.5 × the interquartile range) and lower (Q1 − 1.5 × interquartile
range) limits. Values outside the upper and lower limits are “outliers” and are shown by
individual symbols.
RNA Extraction and Quantitative Real-Time PCR
Intestinal tissue was homogenized in Trizol reagent (Invitrogen) and RNA extracted using
standard phenol-chloroform methodologies. Reverse transcription was performed using the
SuperscriptII reverse transcriptase kit (Invitrogen) and Random hexamers (Invitrogen) as per
the manufacturer's instructions. DyNAmo HS (hot-start) SYBR green supermix (Finnzymes)
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was used and the PTC-200 Peltier thermal cycler and Chromo4 continuous fluorescence
detector (both MJ Research) were used in conjunction with Opticon Monitor analysis
software (Version 2.03, MJ Research) to calibrate and run the reaction. Primers sequences
for FAK were CTATCAACAGGTGAAGAGT GAC (F),
CTTGACAGAATCCAGTAAACTC (R).
Enrichment for Epithelial Cells
In order to obtain a population of cells enriched for epithelial cells, an epithelial extraction
protocol based on that of (Bjerknes and Cheng, 1981) was performed on freshly harvested
intestine. In brief, a 10 cm section of small intestine was flushed well with water before
being tied off at one end and inverted over a 4 mm glass rod. Vibration was then applied to
the glass rod, and the intestine was placed in 10 mM EDTA in Hanks' balanced salt solution
(HBSS; GIBCO) at 37°C for 15 min. The intestine was then moved into a clean tube of 10
mM EDTA/HBSS and incubated in the same fashion for a further 15 min. Centrifugation
(2700 × g, 4°C, 15 min) yielded a pellet containing predominantly epithelial cells.
Western Blotting
Protein was extracted from epithelial-enriched samples by standard methods using lysis
buffer (20 mM Tris-HCl [pH 8.0], 2 mM EDTA [pH 8.0], 0.5% [v/v] NP-40) containing
protease inhibitors (Complete Mini Protease inhibitor tablets, Roche) and phosphatase
inhibitors (25 mM sodium β-glycerophosphate, 100 mM sodium fluoride, 20 nM Calyculin
A, 10 mM sodium pyrophosphate). Solubilized proteins (30 μg) were separated by standard
SDS-PAGE on a 10% polyacrylamide separating gel with 5% stacking gel, and subsequently
transferred to PVDF membrane (Hybond-P, Amersham Biosciences) by standard methods.
Primary antibodies and conditions used to probe blots were rabbit anti-FAK (1:1000; Cell
Signaling), mouse anti-β-actin (1:5000; Sigma), anti-p53 (1:1000; BD), and anti-pAktS473,
anti-tAkt, and anti-tubulin (all 1:1000, Cell Signaling). Appropriate HRP-conjugated
secondary anti-rabbit or anti-mouse antibodies were used (Amersham Biosciences).
Immunohistochemistry and In Situ Hybridization
IHC and ISH were performed as described previously (Sansom et al., 2004; Gregorieff et al.,
2005). Primary antibodies used for IHC were anti-β-catenin (1:50; Transduction Labs), anti-
FAK (1/200; Cell Signaling), anti-c-Myc (1:50; Upstate), anti-pAktSer473 (1/50; Cell
Signaling), anti-pGSK3βSer9 (1/50; Cell Signaling), anti-p-mTORSer2448 (1/100; Cell
Signaling), anti-p21 M19 (1/400; Santa Cruz), anti-p53 CM5 (1/500; Vector Laboratories),
and anti-lysozyme (1:100; Neomarkers).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. FAK Is Upregulated following Wnt Signaling Activation In Vivo
(A–C) FAK IHC in wild-type (A) and regenerating epithelium (B and C). Note low levels of
FAK expression in normal intestinal epithelium (A) which markedly increase in
regenerating epithelium (B) 3 days after gamma irradiation. (C) Lack of FAK expression in
dying c-Myc-deficient crypts (arrows) 3 days after gamma irradiation.
(D and E) FAK IHC in AhCre+Apcfl/fl (labeled Apcfl/fl) intestines 4 days postinduction (PI).
IHC shows a clear upregulation of FAK in Apc-deficient intestines (D). This is highlighted
at the margin of the Apc-deficient cells where nonrecombined retained villi enterocytes have
low levels of FAK protein (black arrow), while Apc-deficient cells (red arrow) have very
high levels of FAK protein (E). The reason why there are still wild-type cells retained 4 days
following Cre activation is that Apc-deficient cells do not migrate efficiently (see Sansom et
al., 2004).
(F) FAK IHC in AhCre+Apcfl/flMycfl/fl (labeled Apcfl/flMycfl/fl) intestines 4 days after Apc
loss. IHC shows that FAK is not upregulated in double-mutant Apc Myc intestines.
(G) Immunoblotting comparing FAK levels in epithelial extracts from AhCre+Apcfl/fl and
AhCre+Apcfl/flMycfl/fl intestines 4 days PI. Note there is clearly reduced FAK protein
expression in the AhCre+Apcfl/flMycfl/fl intestines.
(H) FAK IHC of adenomas of AhCre+Apcfl/+Fak+/+ mice 300 days following Cre induction.
Note FAK is upregulated in both adenomas (solid red arrow) and single aberrant crypts
(dashed red arrow) compared with normal epithelium (black arrow).
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Figure 2. c-Myc Is Required for Intestinal Regeneration
(A) Wild-type regenerating crypts are enlarged following 14 Gy irradiation (black arrows).
(B) AhCre+Mycfl/fl intestines day 6 PI, 3 days following 14 Gy irradiation. Note there are
now large areas of intestine denuded of crypts with only occasional enlarged regenerative
crypts (denoted by black arrow). Dying/cystic crypts are denoted by red arrows.
(C) IHC for c-Myc in wild-type intestine day 6 PI. Note c-Myc-positive cells are located at
the base of the crypt.
(D and E) IHC for c-Myc in AhCre+Mycfl/fl intestine day 6 PI, 3 days following 14 Gy
irradiation. The regenerative intestinal crypts (black arrows) are all c-Myc proficient. These
are thus defined as escaper crypts.
(F) Boxplot showing significant reduction in surviving crypts between
AhCre+Mycfl/flRosaMyc/+ (labeled Rosa Myc) and wild-type AhCre+Myc+/+Rosa+/+ mice
(Mann-Whitney p = 0.04, n = 4).
(G) H&E staining showing absence of functional crypts in AhCre+Mycfl/flRosaMyc/+ (labeled
Mycfl/flRosaMyc/+) mice, 72 hr following 14 Gy irradiation.
(H) FAK IHC showing FAK expression is generally absent from dying AhCre+Mycfl/fl
intestinal crypts 72 hr following irradiation (shown by red arrows). Black arrow denotes
regenerating escaper crypt, which has high levels of FAK protein and would express c-Myc
(see Figure S1).
(I) FAK IHC performed on AhCre+Mycfl/flRosaMyc/+ intestinal epithelium 72 hr following
14 Gy irradiation showing absence of expression in the intestinal crypts.
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Figure 3. FAK Is Required for Intestinal Regeneration
(A) H&E staining of small intestine after 14 Gy irradiation showing multiple regenerating
crypts in wild-type mice and only one regenerating crypt in AhCre+Fakfl/fl mice (black
arrow).
(B) Bar graph showing significant decrease in number of regenerating crypts in small
intestine of AhCre+Fakfl/fl mice compared with wild-type, 72 hr after 14 Gy irradiation.
(C) Corresponding high levels of FAK seen by IHC in FAK-proficient regenerating crypts
72 hr after 14 Gy irradiation. Black arrows show regenerating escaper crypts with high FAK
expression. Inset shows close up regenerating crypt with high FAK expression and hence
has escaped cre-mediated recombination and not deleted FAK.
(D and E) Boxplots showing significantly increased apoptosis and reduced mitosis in
AhCre+Fakfl/fl intestine compared with AhCre+Fak+/+ intestine 48 hr following gamma
irradiation (Mann-Whitney p > 0.05, n = at least 4).
(F) H&E staining of small intestine after 14 Gy irradiation showing multiple regenerating
crypts in wild-type mice, and only one regenerating crypt in VillinCreERFakfl/fl mice 72 hr
following irradiation (black arrows).
(G) Bar graph showing significant decrease in number of regenerating crypts in the small
intestine of VillinCreERFakfl/fl mice compared with wild-type, 72 hr after 14 Gy irradiation.
Ashton et al. Page 16
Dev Cell. Author manuscript; available in PMC 2012 March 2.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4. Akt Signaling via FAK Is Required for Efficient Regeneration
(A) IHC for p-AktSer473 shows weak staining in wild-type (first panel) and FAK-deficient
crypts (second panel), but increased staining in regenerating crypts following 14 Gy
irradiation (third panel upper). No upregulation was observed in FAK-deficient crypts (third
panel lower: red arrows); however, in the rare escaper FAK-proficient crypts (black arrows),
which efficiently regenerate, high levels of p-Akt were observed.
(B) IHC for p-Akt shows that Akt upregulation is c-Myc dependent. First panel shows weak
p-Akt staining in nonirradiated c-Myc-deficient intestine. Second panel shows upregulation
of p-Akt in a rare escaper c-Myc-proficient regenerating crypt (black arrow), while no
discernable p-Akt staining was observed in the dying c-Myc-deficient crypts (red arrows).
(C) p-GSK3β (a target of Akt) is activated during regeneration. Left panel, nonir-radiated
wild-type crypts showing low levels of p-GSK3β. Right panel shows high levels of p-
GSK3β in wild-type regenerating crypts.
(D) p-mTOR is upregulated during regeneration but not in FAK-deficient crypts. p-mTOR
IHC showing low levels of p-mTOR in wild-type (first panel) and FAK-deficient (second
panel) crypts. Following irradiation, increased levels of p-mTOR are observed in wild-type
regenerating crypts (third panel upper). In FAK-deficient crypts, p-mTOR is not upregulated
(third panel lower: red arrow); however, in the rare escaper regenerating crypts, p-mTOR is
upregulated (black arrow).
(E) “Back to back” IHC staining showing that the large escaper FAK-proficient regenerative
crypts have high levels of p-Akt and p-mTOR expression.
(F) Boxplots showing that mice treated with either rapamycin or PI103 have significantly
fewer surviving crypts than vehicle treated mice following 14 Gy irradiation (Mann-
Whitney, p = > 0.04, n = 4).
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Figure 5. Activation of p-Akt by IGF1 Restores Intestinal Regeneration to FAK-Deficient
Intestines
(A) Boxplot showing regenerating FAK-deficient crypts in AhCre+Fakfl/fl intestines treated
with IGF1 (Mann-Whitney, p = 0.04), compared with vehicle treated AhCre+Fakfl/fl
intestines.
(B and C) FAK IHC showing the presence of enlarged FAK-deficient crypts (red arrows),
which are the same size as FAK-proficient crypts (black arrows).
(D and E) p-Akt and p-mTOR IHC showing all crypts from AhCre+Fakfl/fl intestines treated
with IGF1 now have high levels of both p-Akt (D) and p-mTOR (E).
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Figure 6. FAK Is Required for Intestinal Transformation following Apc Loss
(A) H&E-stained sections from AhCre+Apcfl/fl (labeled Apcfl/fl) and AhCre+Apcfl/flFakfl/fl
(labeled Apcfl/fl Fakfl/fl) intestines 4 days PI. Note that Apc-deficient crypts look much
enlarged.
(B) FAK IHC in AhCre+Apcfl/fl and AhCre+Apcfl/flFakfl/fl intestines 4 days after Apc loss.
IHC shows that FAK expression is lost in doube-mutant Apc Fak intestines.
(C) Bar graph showing reduced BrdU positivity and increased apoptosis in
AhCre+Apcfl/flFakfl/fl intestinal enterocytes compared with AhCre+Apcfl/fl mice (Mann-
Whitney p = 0.04, n ≥ 4). Errors bars represent SD.
(D and E) β-catenin and c-Myc IHC performed upon AhCre+Apc+/+ (labeled WT),
AhCre+Apcfl/fl and AhCre+Apcfl/flFakfl/fl intestines 4 days PI. Note both Apc and Apc Fak-
deficient intestines have increased levels of nuclear β-catenin and c-Myc compared with
WT. Nuclear β-catenin is arrowed in the inset.
(F and G) p-Akt and p-mTOR IHC performed upon AhCre+Apcfl/fl and AhCre+Apcfl/flFakfl/fl
intestines 4 days PI. Note reduction in staining in the double-mutant Apc Fak intestines.
(H) Intestinal tumor-free survival of AhCre+Apcfl/+Fak+/+ (blue line) and
AhCre+Apcfl/+Fakfl/fl (green line) mice up to 500 days. No AhCre+Apcfl/+Fakfl/fl mice
developed intestinal disease. All the AhCre+Apcfl/+ Fak+/+ mice became ill with intestinal
tumors with a median onset of 344 days p ≥0.005 log rank.
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